42 results
8-K
EX-99.5
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
and streamline the management of its financial, accounting, human resources and other functions. However, such a system would likely require Kineta to complete
424B3
KA
Kineta Inc
10 Nov 22
Prospectus supplement
4:21pm
of Operations and Human Resources. Kineta’s senior management may terminate their employment with Kineta at any time and will continue to be able
8-K
EX-10.1
rc6 2c5vid
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am